Results 421-440 of 1,051,132 for in 'Dáil debates' OR (speaker:Paul McAuliffe OR speaker:Patrick Costello OR speaker:Michael Lowry OR speaker:Malcolm Noonan OR speaker:Marc Ó Cathasaigh OR speaker:Neasa Hourigan) in 'Committee meetings'

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Neasa Hourigan: I am always the boring person who says it is really cost-effective.

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Neasa Hourigan: It is just somebody who rings you up, reminds you not to forget about your appointment and walks in with you.

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Neasa Hourigan: When that happens, in Mr. Perth's experience, what is the language that is used? Is it said the people need to go and get treatment for bipolar first?

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Neasa Hourigan: It is that dual diagnosis thing that they just will not do it.

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Neasa Hourigan: Am I right in thinking that if people go in somewhere with bipolar or whatever it might be to ask for treatment, they will often be told they need to get clean first?

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Neasa Hourigan: It is a catch-22.

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Neasa Hourigan: They would be turned away.

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: I acknowledge the Cathaoirleach's new position. I have no doubt but that she will continue the good work of the previous Chair in chairing this committee and doing it in a cross-party way. Our work in this committee is very important, but so is the way we do our work. It is important and different from other committees. I acknowledge this point. I thank Mr. Gloster and all the team for...

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: I saw a figure regarding the outpatient waiting lists having been reduced by 50,000 people. Mr. Gloster is saying this is a real reduction rather than a validation exercise.

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: Will Mr. Gloster repeat that figure?

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: I accept that point. The experience just shone a light on the outpatients waiting list for me.

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: We do not know, but this may be the last or the second last meeting of this committee. It will certainly be the last meeting during this Dáil when Mr. Gloster will be before us anyway.

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: I am very much cognisant of the volume of money associated with this hearing. We are talking about €23.5 billion. Many Government Departments could be folded into that figure. In 2019, the figure was €16 billion. Essentially, there has been a 46% increase in the funding of the HSE over the past four years, that is, the lifetime of this Government. In 60 seconds, can Mr....

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: I would love to explore that point more but I just do not have the time. Turning to the non-compliant procurement, this is the first thing we look at in this committee. The HSE estimated that the total expenditure on goods and services subject to procurement rules was €4.2 billion. Again, this amount is multiples of an entire Government Department in some cases. The idea that...

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: When the HSE did the self-assessed audit, there was a very significant percentage of either non-co-operation or where you could not identify the purchaser. The figure of 12% actually could be higher.

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: Just to return to that point, Mr. Mulvany is saying the figure of 12% does include the 13% of invoices within the scope of the exercise where either the manager responsible could not be identified or where the manager failed to respond to the exercise. He is saying that 13% is deemed non-compliant and is included in the 12%.

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: Will the C and AG confirm that?

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: Can we get a note back on that?

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Marc Ó Cathasaigh: Comhghaideas leis an gCathaoirleach. I do not intend to dwell on this but I have one question about that high earner. Mr. Gloster used the word "abhorrent", with which I think most of us would agree. Are we going to face a similar scenario? He talked about the new consultant contracts and the employment of more consultants, which is the ultimate aim, but are legacy contracts in place such...